Table 1.
The clinical parameters of patients with hyperuricemia and controls.
| Variable | CON (n = 30) | HUA (n = 30) |
|---|---|---|
| Age | 51.80 ± 10.28 | 55.40 ± 15.32 |
| Sex (M/F) | 18/12 | 25/5 |
| Height | 165.63 ± 7.55 | 165.20 ± 7.53 |
| Weight | 62.54 ± 10.63 | 66.17 ± 9.27 |
| BMI (kg/m2) | 20.70 ± 2.93 | 24.21 ± 2.62* |
| Systolic pressure (mmHg) | 131.80 ± 16.89 | 142.97 ± 16.58 |
| Diastolic pressure (mmHg) | 75.47 ± 11.65 | 80.13 ± 12.93 |
| UA (μmol/L) | 311.11 ± 85.59 | 588.37 ± 90.57** |
| Cr (μmol/L) | 96.27 ± 21.91 | 124.75 ± 4.36** |
| TC (mmol/L) | 4.21 (2.77–6.10) | 4.89 (3.51–6.45)* |
| TG (mmol/L) | 1.95 (0.76–6.13) | 2.48 (0.89–5.22)* |
| HDL-C (mmol/L) | 1.04 ± 0.20 | 1.02 ± 0.22 |
| LDL-C (mmol/L) | 2.88 ± 0.65 | 3.17 ± 0.64 |
| FIns (mmol/L) | 6.86 (1.87–19.37) | 11.22 (3.8–26.44)** |
| HOMA-IR | 1.52 (0.39–4.99) | 2.46 (0.62–6.82)** |
| FPG (mmol/L) | 4.78 ± 0.68 | 4.86 ± 0.65 |
BMI, body mass index; CON, control groups; Cr, creatinine; FPG, fasting plasma glucose; FIns, fasting insulin; HDL-C, high density lipoprotein cholesterol; HOMA-IR, HOMA insulin resistance index; HUA, hyperuricemia; LDL-C, low-density lipoprotein cholesterol; TC, total cholesterol; TG, triglycerides; UA, uric acid. Data are expressed as means ± SEM; *P < 0.05; **P < 0.01.